2026_Oct_CPHI_Milan_Leaderboard

Dr Greg Moakes
Executive Vice-President of Business Development

Is this your profile?

About

Greg Moakes, PhD, is Executive Vice-President of Business Development for LTS Device Technologies Division. Dr Moakes holds a PhD in Chemistry from the Georgia Institute of Technology (Atlanta, GA, US) and an MBA from the Southern Methodist University (Dallas, TX, US). His career has been focused on drug delivery, first specialising in solid-implant dosage formulations and more recently high-volume subcutaneous delivery via on-body delivery systems.

Contributions

WHY SMARTER WEARABLES ARE THE SIMPLE ANSWER TO INTELLIGENT DRUG DELIVERY

Dr Greg Moakes considers how complex devices, such as LTS’s Sorrel™ on-body delivery system can facilitate the self-administration of injectable therapies while continuously monitoring and verifying the device’s critical delivery functions.

More contributions

Off The Critical Path: Bringing Device Strategy Forward In Combination Product Development

David Karvani and Greg Moakes discuss how early collaboration with device development partners can help pharma companies navigate the technical and regulatory complexities of combination product development.

ADVANCING CANCER CARE THROUGH ON-BODY SUBCUTANEOUS INJECTIONS: THE ONCOLOGY COMMUNITY’S PERSPECTIVE

Dr Greg Moakes discusses the role that on-body delivery systems have to play in modernising the delivery of oncology drugs, digging into the survey results of over 200 attendees of the American Society of Clinical Oncology 2025 Global Meeting as to their opinions on the place of this pivotal technology in oncological practice.

THE POWER OF PARTNERSHIP AND CLOSE COLLABORATION FOR FILLING ON-BODY INJECTORS

Mary Lou Glotzbach and Dr Greg Moakes consider the implications of the increasing demand for high-volume injections across the drug delivery industry, and how technologies such as wearable injectors are creating novel challenges for the fill-finish process due to the novel containers involved, making the case that it is only through clear communication and close collaboration between partners that these challenges can be met and surmounted.

TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING

Greg Moakes and Tzach Sadi the process and benefits of automating the production process for its on-body injector device, Sorrel™.

Top